Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2858 Target Snapshot

Mu-type opioid receptor · SINGLE PROTEIN · Mus musculus

1,100Compounds
244Assays
20Approved Drugs
1,315.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P42866. Use UniProt P42866 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P42866 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Mu-type opioid receptor as ChEMBL target CHEMBL2858, mapped to UniProt P42866. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Mu-type opioid receptor
SINGLE PROTEIN · Mus musculus
As of 2026-09-13
ChEMBL target ID
CHEMBL2858
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P42866
Mu-type opioid receptor
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Mu-type opioid receptor is the right protein anchor across sources, using UniProt P42866 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMu-type opioid receptor
UniProt AccessionP42866
Component TypeProtein
Sequence Length398 aa

Mu-type opioid receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Mu-type opioid receptor, mapped to UniProt P42866. Sequence length is 398 aa.

Mapped IDP42866
Review nameMu-type opioid receptor
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

20
Approved
1
Phase III
2
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC50161.0
KI794.0
EC50330.0
KD30.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2311157 10.62 Ki 0.024 Preclinical
CHEMBL2016678 10.31 Ki 0.049 Preclinical
CHEMBL3215908 10.28 Ki 0.052 Preclinical
CHEMBL3339374 10.28 Ki 0.052 Preclinical
CHEMBL121403 10.22 Ki 0.06 Preclinical
CHEMBL4128945 10.15 IC50 0.07 Preclinical
CHEMBL3216338 10.12 Ki 0.075 Preclinical
CHEMBL338510 10.1 Ki 0.08 Preclinical
CHEMBL3216579 10.09 Ki 0.081 Preclinical
CHEMBL2016675 10.01 Ki 0.097 Preclinical
Distribution

pChEMBL Value Distribution

45
5.0
49
5.5
75
6.0
100
6.5
133
7.0
126
7.5
155
8.0
205
8.5
201
9.0
104
9.5
pChEMBL
Approved Drugs

Approved Drugs

OLICERIDINE
CHEMBL2443262
Approved 2020
NALFURAFINE
CHEMBL267495
Approved 2009
NALFURAFINE HYDROCHLORIDE
CHEMBL490665
Approved 2009
LEVORPHANOL
CHEMBL592
Approved 1991
NALTREXONE
CHEMBL19019
Approved 1984
MORPHINE
CHEMBL70
Approved 1984
BUPRENORPHINE
CHEMBL511142
Approved 1981
NALOXONE
CHEMBL80
Approved 1971
FENTANYL
CHEMBL596
Approved 1968
OXYMORPHONE
CHEMBL963
Approved 1959
OXYCODONE
CHEMBL656
Approved 1950
Assay Landscape

Assay Landscape

244
Total Assays
786
Tested Compounds
3
Assay Types
Functional — 125 assays, 248 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 53 147 7.5
tissue-based format 29 23 7.6
assay format 25 16 7.0
organism-based format 10 0
cell membrane format 8 62 8.6
Binding — 118 assays, 786 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 30 151 7.8
cell membrane format 26 172 8.2
cell-based format 26 251 8.5
tissue-based format 20 90 7.9
assay format 14 119 7.7
organism-based format 2 3 9.8
ADME — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell membrane format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine